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cd T Cells Augment Rejection of Skin Grafts by
Enhancing Cross-Priming of CD8 T Cells to
Skin-Derived Antigen
Azad Rahimpour1,2, Stephen R. Mattarollo1,3, Michelle Yong1, Graham R. Leggatt1, Raymond J. Steptoe1
and Ian H. Frazer1
Gamma delta T cells (gd T cells) possess innate-like properties and are proposed to bridge the gap between
innate and adaptive immunity. In this study, we explored the role of gd T cells in cutaneous immunity using
a skin transplantation model. Following engraftment of skin expressing cell–associated model antigen (Ag)
(ovalbumin) in epithelial keratinocytes, skin-resident gd T cells enhanced graft rejection. Although the effector
function of CD8 Tcells was intact in the absence of gd T cells, cross-priming of CD8 Tcell to graft-derived Ag was
impaired in the absence of gd T cells. The reduced graft rejection and graft priming of gd T-cell–deficient mice
was evident in both acutely inflamed and well-healed grafting models. Furthermore, expression of the CD40
activation marker on migrating dendritic cells was lower in TCRd/ mice compared with wild-type mice,
regardless of the presence or absence of inflammation associated with grafting. These results indicate that gd
T cells enhance graft priming and consequently the likelihood of a successful immune outcome in the context
of skin graft rejection, suggesting that gd T cells may be an important component of immunity to epithelial
cancers or infection.
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INTRODUCTION
Gamma delta T cells (gd T cells) are a minor sub-population
of T cells in the circulation; however, they are highly enriched
in epithelial tissues such as skin, gut, lungs, and the geni-
tourinary tract (Allison and Havran, 1991). gd T-cell–deficient
(TCRd/) mice have perturbed epithelial physiology and
immune responsiveness upon various biological and non-
biological challenges. A skin-resident subset of gd T cells
called dendritic epidermal T cells (DETCs) has a critical role
in tumor surveillance following treatment of skin with
dimethylbenzanthracine and tetradecanoylphorbol (Girardi
et al., 2001). The intestinal tract of TCRd/ mice has been
shown to exhibit increased immunopathology and epithelial
damage following infection with Eimeria vermiformis or
treatment with dextran sodium sulfate in a dextran sodium
sulfate–induced model of mouse colitis (Roberts et al., 1996;
Chen et al., 2002). Ozone treatment and infection with
Nocardia asteroides results in increased pulmonary damage
and high lethality in gd T-cell–deficient mice (King et al.,
1999). In the kidneys, the severity of adriamycin-induced
nephropathy is dampened by intraepithelial gd T cells
(Wu et al., 2007).
Notwithstanding the fact that the majority of research on
intraepithelial gd T cells has been on the role of gd cells in
cutaneous immunity, our understanding of the involvement
of gd T cells in the immune processes in the skin is
incomplete. Although the role of skin-resident gd T cells in
tumor surveillance, wound healing, and homeostasis in the
skin has been elaborately described (Girardi et al., 2001;
Jameson et al., 2002; Sharp et al., 2005; Jameson and
Havran, 2007), the details of how skin-resident gd T cells
regulate the function of other skin-associated immune
cells have not been extensively studied. For example, the
effects of gd T cells on cross-presentation of skin-derived
antigens (Ags) in generating adaptive immune responses is
largely unknown.
Skin transplantation has been used in research as a model
to study histocompatibility, cutaneous immunity, and the
pathophysiology of solid organ transplant rejection (Klein,
1975; Rosenberg and Singer, 1992). The paradigm of skin
graft rejection involves the presentation of skin-derived Ags
by Ag-presenting cells in the lymph node to CD4 and
CD8 T cells, which subsequently results in the generation of
ORIGINAL ARTICLE
1656 Journal of Investigative Dermatology (2012), Volume 132 & 2012 The Society for Investigative Dermatology
Received 25 August 2011; revised 8 December 2011; accepted 31 December
2011; published online 23 February 2012
1The University of Queensland Diamantina Institute, Princess Alexandra
Hospital, Woolloongabba, Queensland, Australia; 2Department of
Microbiology and Immunology, The University of Melbourne, Melbourne,
Victoria, Australia and 3Cancer Immunology Program, Peter MacCallum
Cancer Center, East Melbourne, Victoria, Australia
Correspondence: Ian H. Frazer, The University of Queensland Diamantina
Institute, Princess Alexandra Hospital, Woolloongabba, Queensland 4102,
Australia. E-mail: i.frazer@uq.edu.au
Abbreviations: Ag, antigen; DC, dendritic cell; DETC, dendritic epidermal
T cell; DLN, draining lymph node; gd T cell, gamma delta T cell; OVA,
ovalbumin; Tg, transgenic
adaptive immune responses (Rosenberg et al., 1987; Sawada
et al., 1997; Lakkis et al., 2000). The role of skin-resident
gd T cells in this process has not been described. This
study describes the role of gd T cells in rejection of ovalbu-
min (OVA)-expressing skin grafts. We show that skin-resident
gd T cells enhance skin graft rejection. We also show that
although cross-priming of CD8 T cells to Ags delivered
subcutaneously in conjunction with an adjuvant is intact in
TCRd/ mice, cross-priming to skin-derived Ags is impaired
in gd T-cell–deficient mice in both acutely inflamed and
well-healed skin grafts. Furthermore, we show that although
trafficking of skin-derived dendritic cells (DCs) is not impaired
in gd T-cell–deficient mice, the expression of the CD40
co-stimulatory molecule on migrating DCs is lower in
transplanted and naive TCRd/ mice compared with
wild type. Therefore, we describe a role for gd T cells in
cutaneous immunity, which to our knowledge is previously
unreported.
RESULTS
Skin-resident cd T cells enhance rejection of OVA-expressing
skin grafts
Immunocompetent mice reject otherwise syngeneic skin
expressing OVA in keratinocytes from a keratin 5 promoter
(K5mOVA mice) (Azukizawa et al., 2003). To establish the
contribution of gd T cells to skin graft rejection, we generated
TCRd/OVAþ / mice by crossing TCRd/ (C57BL/6 strain)
and K5mOVA (C57BL/6 strain) mice. TCRd/mice were double
grafted with skin from TCRd/ (control) and TCRd/OVAþ /
mice, and the rejection rate was compared with that of
C57BL/6 (control) and K5mOVA grafts by wild-type C57BL/6
mice. Control grafts in both groups were accepted indefi-
nitely, and while 100% of K5mOVA grafts were rejected
promptly by C57BL/6 mice as previously described, only
64% of TCRd/OVAþ / grafts were rejected by TCRd/
mice (Figure 1a).
To clarify whether donor or host gd T cells were con-
tributing to rejection of OVA grafts, K5mOVA skin was
transplanted onto TCRd/ mice, eliminating host gd T cells,
and TCRd/OVAþ / skin (devoid of donor gd T cells)
was grafted onto wild-type mice. In both groups, 100%
of grafts were rejected robustly by their respective reci-
pients, suggesting that the presence of gd T cells in either
the donor or the recipient is sufficient for skin graft rejec-
tion and both must be absent for prolonged survival.
Robust rejection of K5mOVA grafts by TCRd/ mice shows
that in this model circulating gd T cells are redundant and
that skin-resident gd T cells enhance rejection of OVA-
expressing skin grafts (Figure 1b). To confirm that skin, rather
than circulating gd T cells, was responsible for enhanced
rejection, TCRd/ mice were grafted with TCRd/OVAþ /
transgenic skin and were administered splenocytes from
wild-type or TCRd/ animals (one donor spleen per
recipient). No difference in the rate of graft rejection was
observed (Figure 1c), further confirming the finding that
circulating gd T cells do not contribute to graft rejection in
this model.
Impaired CD8 T-cell priming to acutely inflamed graft-derived
Ags in TCRd/ mice
Skin graft rejection generally requires priming of CD8 T cells
to graft-derived Ags and generation of an Ag-specific effector
T-cell response (Rosenberg et al., 1987; Rosenberg and
Singer, 1992; Tak and Mak, 2006). To determine whether gd
T cells contributed to the priming phase, wild-type and
TCRd/mice were transplanted with K5mOVA and TCRd/
OVAþ / skin grafts, respectively. Twenty days after grafting,
spleens were taken and OVA-specific IFNg-secreting CD8
T-cell responses were assessed by IFNg ELISPOT stimulated
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Figure 1. Skin-resident cd T cells enhance rejection of ovalbumin (OVA)-
expressing skin grafts. (a) Graft survival for K5mOVA (n¼19), C57 (n¼10),
TCRd/OVAþ / (n¼10), and TCRd/ (n¼ 19) grafts transplanted onto C57
and TCRd/ recipients (**Po0.01). (b) Graft survival for K5mOVA grafts
transplanted onto C57 (n¼ 10) or TCRd/ (n¼ 15) recipients (P¼NS) and
TCRd/OVAþ / grafts transplanted onto C57 (n¼ 13) recipients. (c) Graft
survival for TCRd/OVAþ / grafts transplanted onto TCRd/ animals,
recipient of 1 108 splenocytes from TCRd/ (n¼ 5) or C57 (n¼4) mice,
or without transferred splenocytes (n¼5) (P¼NS). Graft survival curves
were assessed for significance using Kaplan–Meier survival analysis.
NS, nonsignificant; WT, wild type.
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with the cognate Ag SIINFEKL. Mean ELISPOT number for
TCRd/ recipients was significantly lower than that for C57
mice (Figure 2a). IFNg was undetectable from splenic CD8 T
cells of TCRd/ mice that had not rejected their skin grafts
(data not shown), suggesting that acquisition of the capacity
to reject a skin graft correlated with acquisition of effector
function by Ag-specific CD8 T cells. To confirm this finding
in vivo, OVA-specific T-cell proliferation was assessed by
transfer of carboxyfluorescein diacetate succinimidyl ester
(CFSE)-labeled Ly5.1þ OT-I cells into wild-type and TCRd/
mice, which were thereafter transplanted with TCRdþ /
OVAþ / and TCRd/OVAþ / grafts, respectively. Nine
days after grafting, mean proliferation index of adoptively
transferred OT-I cells was higher in graft draining lymph
nodes (DLNs) of wild-type mice, indicating faster prolifera-
tion in wild-type mice compared with gd T-cell–deficient
mice (Figure 2b).
To determine whether the abrogation in CD8 T-cell
priming was a systemic defect in TCRd/ mice or a phe-
nomenon seen only in priming to skin graft–derived Ags,
wild-type and TCRd/ mice were immunized subcuta-
neously with OVA and QuilA. IFNg production by splenic
CD8 T cells harvested after 7 days and rechallenged in vitro
with SIINFEKL was comparable between wild-type and TCRd/
mice (Figure 2c). Similarly, in vivo proliferation of adoptively
transferred CFSE-labeled Ly5.1þ OT-I cells in DLNs after
OVA and QuilA immunization was comparable between
wild-type and TCRd/mice (Figure 2d). These results indicate
that CD8 T-cell priming in the absence of gd T cells is
impaired only when Ag expression is restricted to epithelial
cells of the skin.
Intact effector CD8 T-cell function in TCRd/ mice
As gd T cells were shown to be important in CD8 T-cell
priming to skin grafts, we examined whether they were
also important in the effector phase of the immune response in
skin graft rejection. Wild-type and TCRd/ mice were pre-
immunized with OVA and QuilA, and 7 days later each
group was transplanted with their relevant OVA-expressing
grafts (K5mOVA onto C57BL/6 and TCRd/OVAþ / onto
TCRd/). All grafts were rejected by day 9 after grafting
(Figure 3a), suggesting that Ag-specific effector functions
necessary for skin graft rejection were not significantly
impaired in OVA-primed mice lacking gd T cells.
To confirm this finding, RAG/2CTCR transgenic (Tg) mice
that lack OVA-specific CD8 and gd T cells (Sha et al., 1988)
were transplanted with either K5mOVA or TCRd/OVAþ /
skin grafts and simultaneously administered 1 103 in vitro-
activated OT-I cells, which have been previously shown
to be necessary and sufficient to enable rejection of
K5mOVA grafts from a T-cell–deficient mouse (Kenna
et al., 2008; Broom et al. 2010). In both groups, recipient
mice rejected all skin grafts in a median time of 11 days
(Figure 3b), confirming that effector functions necessary
for skin graft rejection are not impaired in the absence of
gd T cells.
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Figure 2. Graft priming, but not systemic priming, to ovalbumin (OVA) is impaired in TCRd/ mice. (a) C57 (n¼ 7) and TCRd/ (n¼ 8) mice were grafted
with K5mOVA and TCRd/OVAþ / skin, respectively. Control mice were immunized with OVA þ QuilA or QuilA only. After 20 days, SIINFEKL-specific
IFNg-producing CD8 T cells from the spleen were assessed (**Po0.01). (b) C57 (n¼7) and TCRd/ mice (n¼ 7) were grafted with TCRdþ /OVAþ / and
TCRd/OVAþ / skin, respectively. All mice received CFSE-labeled OT-I cells. After 9 days, OT-I cell proliferation in graft draining lymph nodes (DLNs) was
analyzed (*Po0.05). (c) C57 and TCRd/mice (n¼4) immunized with OVA þ QuilA or QuilA only. SIINFEKL-specific IFNg-secreting T cells were assessed in
the spleen after 7 days (P¼NS). (d) T-cell proliferation in DLNs of TCRd/ and C57 mice that received CSFE-labeled OT-I cells, and were immunized with
QuilA or OVA þ QuilA, was assessed after 4 days (P¼NS). FACS histograms show representative CFSE dilution. Unpaired t-test was used for statistical analysis.
CFSE, carboxyfluorescein diacetate succinimidyl ester; NS, nonsignificant; SFU, spot-forming units.
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Impaired CD8 T-cell priming to well-healed graft-derived Ags
in TCRd/ mice
CD8 T-cell priming to OVA Ag by freshly placed K5mOVA
grafts was impaired in the absence of gd T cells (Figure 2a and
b). To determine whether the local inflammation associated
with grafting, which contributes to effective priming to skin
graft–associated Ags (Zhong et al., 2008), is influenced by gd
T cells, we first examined the proliferation of CFSE-labeled
OT-I cells transferred into TCRdþ /OVAþ / or TCRd/
OVAþ / mice. At 42 h after transfer, significantly more OT-I
cell proliferation was observed in the skin DLNs of
gd T-cell replete mice (Figure 4a).
In a second approach, wild-type and TCRd/ mice were
transplanted with TCRdþ /OVAþ / and TCRd/OVAþ /
skin grafts, respectively. All recipient mice were initially
treated with a CD8b-depleting antibody to deplete CD8
T cells, and therefore initially prevent skin graft rejection in
the acute inflammatory phase. Graft rejection was monitored
until day 90, by which time CD8 T cells had recovered.
Although nearly 50% of grafts were rejected in the wild-type
group, graft rejection was completely absent in the gd
T-cell–deficient group (Figure 4b). At day 90, mice that had
not rejected their skin grafts were injected with CFSE-labeled
OT-I cells to determine the proliferation rate of OT-I cells in
the presence or absence of gd T cells. Graft DLNs were taken
42 h later, and proliferation of OT-I cells was analyzed.
Proliferation of OT-I cells was slower in the absence of gd T
cells compared with that in their presence (Figure 4c). These
data suggest that inflammation associated with skin grafting
enhances T-cell priming and graft rejection, and in the
absence of inflammation skin graft rejection is further impaired
in TCRd/ mice. This highlights the potential relevance of
gd T cells in general physiological or chronic inflammatory
cutaneous settings in addition to their role in acutely inflamed
transplantation model.
Maturation, but not trafficking of migrating DCs, is impaired in
TCRd/ mice
Wound healing and macrophage infiltration into skin are
impaired in TCRd/ mice (Jameson et al., 2002, 2005). To
assess whether the absence of gd T cells could affect the
migration of skin-associated dendritic cells and therefore
influence cross-priming of CD8 T cells, we assessed DC
migration to lymph nodes in wild-type and TCRd/ mice.
We observed no differences in the migrating capacity of
major histocompatibility complex-IIhi CD11chi DCs to DLNs
following FITC painting of syngeneically grafted or non-
grafted wild-type and TCRd/ skin (Figure 5a).
In a second approach, TCRd/ mice were bred with
Ly5.1þ Ptprca mice to create congenically marked TCRd/
mice. Ly5.2þ C57BL/6 and Ly5.2þ TCRd/ mice were tran-
splanted with Ly5.1þ C57BL/6 and Ly5.1þ TCRd/ skin.
Four days after transplantation, Ly5.1þ migrating skin DC
populations were assessed in the DLNs and were found to be
similar between wild-type and TCRd/ mice (Figure 5b).
Having observed no differences in the migration pattern of
skin DCs, the activation state of migrating DCs was subse-
quently assessed by expression of CD40 co-stimulatory
molecule on DCs from non-grafted and syngeneically grafted
wild-type and TCRd/ mice. Modest but consistently lower
levels of CD40 expression were observed in non-grafted and
grafted TCRd/ mice when compared with non-grafted and
grafted wild-type mice, indicating that maturation of DCs
may be impaired in the absence of gd T cells (Figure 5c).
DISCUSSION
In this study, we demonstrate that skin-resident gd T cells
enhance rejection of skin grafts expressing cell-associated
OVA. Although the replacement ab T cells present in the
epidermis of TCRd/mice cannot compensate for the lack of
skin-resident gd T cells, a contribution by recently described
dermal gd T cells (Gray et al., 2011; Sumaria et al., 2011) to
graft rejection cannot be ruled out. Furthermore, we show
that cross-presentation of Ags in the context of skin grafts is
impaired in TCRd/ mice, and this phenomenon is evident
in both acute and well-healed grafts. In the same context,
optimal graft rejection is observed when priming by grafts is
bypassed and achieved by systemic immunization.
In contrast, evidence in the literature suggests a mainly
downregulatory and anti-inflammatory role for gd T cells in
various models (Mombaerts et al., 1993; Mukasa et al., 1995;
Shiohara et al., 1996; D’Souza et al., 1997). On the basis of
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K5mOVA (n¼ 8) and TCRd/OVAþ / (n¼8) grafts, transplanted,
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transferred with 1 103 in vitro-activated OT-I cells (P¼NS). Graft survival
curves were assessed for significance using Kaplan–Meier survival analysis.
NS, nonsignificant.
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the studies published by Gorczynski et al. (1996, 1997) on
the role of gd T cells limiting the rejection of small intestinal
allografts, the authors originally hypothesized that in TCRd/
mice there would be an exacerbated immune response to
skin grafts, and graft rejection would take place more rapidly
than in wild-type mice. The different outcome in the current
work from that found by others (Gorczynski, 1994) may
reflect the micro-anatomical restriction of the Ag to the
epidermis in our model. As a result of this restriction, only
cross-priming by professional APC can lead to priming of the
host animal as opposed to a mixture of cross-priming and
direct priming in allograft settings. Advantageously, this
reductionist system breaks down the process of priming and
focuses merely on cross-priming by professional APCs.
gd T cells lack TCR diversity and are proposed to
recognize evolutionary conserved self-molecules that may
be upregulated following stress (Hayday, 2000); therefore,
any contribution by gd T cells to skin graft rejection cannot be
mediated directly by an Ag-specific response to the expres-
sion of OVA in skin grafts. DETCs can exert direct cytotoxic
effects on transformed, stressed, and cancerous keratinocytes,
which express NGK2D ligands or unknown Vg3 TCR ligands
in vivo and in vitro (Havran et al., 1991; Kaminski et al.,
1993; Nitahara et al., 2006). The relevance of this is highlighted
by the expression of NKG2D ligand on skin grafts acutely
after skin transplantation (Kim et al., 2007). However, the
significance of any potential gd T-cell cytotoxicity in direct
effector function against stressed OVA-expressing skin grafts
is reduced by the observation that gd T cells are redundant in
the effector phase of graft rejection in our model, as pre-
immunization against OVA protein before transplantation
abrogates any defect seen in rejection in TCRd/ mice.
gd T cells can contribute to skin graft rejection through the
production of cytokines, which in turn may enhance the
priming phase of the immune response. In vitro studies have
revealed a capacity for DETC to produce a multitude of
cytokines such as tumor necrosis factor-a, GM-CSF, and
IFN-g (Matsue et al., 1993; Boismenu et al., 1996). However,
the basal levels or the triggers of heightened cytokine produc-
tion by DETCs in vivo have not been fully described.
Furthermore, the necessity, redundancy, or usefulness of
such cytokines produced by DETC in priming has not been
studied in vivo. Induction of Rae-1—a stress molecule—and
NKG2D ligand selectively in the epidermal compartment of
the skin has been reported to result in activation of DETCs,
morphological changes in DETCs and Langerhans cells, and
a modest upregulation of CD86 on Langerhans cells (Strid
et al., 2008). Although the upregulation of CD86 and the
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change of cell shape in Langerhans cells is clearly an indirect
effect of Rae-1 expression, no functional changes by
Langerhans cells in relation to Ag presentation after the
induction of Rae-1 expression was reported. Moreover, it is
not clear whether these changes were caused by DETC
activation or by the infiltration of other NKG2Dþ cells to the
skin. On the basis of the expression of NKG2D ligand in skin
grafts, we found that DETCs at a heightened level of
activation 5 days after grafting evidenced by higher than
baseline CD69 expression (data not shown). Inflammation-
induced Rae-1 expression and subsequent DETC activation
may have a role in augmentation of graft rejection. However,
gd T cells also enhance rejection of well-healed grafts without
evidence of inflammation; thus, there may be multiple
mechanisms through which gd T cells can contribute to
enhanced priming to Ags expressed in grafted skin including
cytokines produced by nonactivated DETC.
One possible mechanism considered for gd T-cell–
mediated enhancement of rejection was that, in their absence,
there was defective migration of DCs from skin to DLNs. This
hypothesis was based on the delay that is known to exist in
the infiltration of macrophages into wounds and healing of
wounds in the skin of gd-deficient mice (Jameson et al., 2002,
2005). This hypothesis was dismissed using FITC painting and
migration of congenically marked (Ly5.1þ ) DCs in wild-type
and TCRd/ mice. However, reduced proliferation of Ag-
specific CD8 T cells was observed in TCRd/OVAþ / (OVA
Tg and gd deficient) mice and in mice grafted with well-healed
TCRd/OVAþ / skin. This, coupled with lower CD40
levels on migrating DCs of TCRd/ mice, may indicate a
tolerogenic form of cross-presentation resulting in poor cross-
priming, a hypothesis that will be examined in further work.
Various studies have reported that cross-presentation of self-
Ags or cognate Ags by DCs not sufficiently activated by
inflammatory stimuli can result in deletional T-cell tolerance
(Waithman et al., 2007; Kenna et al., 2008). Furthermore,
because of the lack of growth factors, epidermal cells in
TCRd/ mice go through 3-fold higher levels of apoptosis
compared with wild type (Sharp et al., 2005). Considering the
tolerogenic effects of apoptosing cells (Griffith et al., 2007;
Green et al., 2009), it may be that cross-tolerance outweighs
cross-priming to epidermal Ags in TCRd/ mice.
The significance of this study is the linking of gd T cells to
an augmented generation of CD8 T-cell responses to cutaneous
Ags. In line with this finding is a study showing that Vg1þ
cells recruited to the lungs of mice infected intranasally with
Bacillus Calmette-Guerin promote the development of CD8
cytotoxic T cells (Dieli et al., 2003). Others have shown
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reduced levels of antibody or antibody-producing plasma
cells after mucosal OVA sensitization in the absence of gd
T cells (Fujihashi et al., 1996; Svensson et al., 2003). From
a more broad perspective, our study is in line with recent
findings demonstrating a contribution by other innate cells,
e.g., NK cells and NKT cells, to cutaneous immunity in the
context of skin transplantation and regulation of CD8 T-cell
immunity (Ito et al., 2008; Kroemer et al., 2008; Mattarollo
et al., 2010a, b).
Characterization of gd T-cell involvement in the genera-
tion of adaptive immune responses in epithelia should faci-
litate development of immunotherapies utilizing gd T cells in
epithelial diseases including cancers and viral infections.
MATERIALS AND METHODS
Mice
C57BL/6 and congenic (Ly5.1þ ) Ptprca mice were obtained from the
Animal Resources Center (Perth, Australia). K5mOVA Tg mice
expressing membrane-bound OVA driven from the K5 promoter
were provided by H Azukizawa (Osaka, Japan) (Azukizawa et al.,
2003). OT-I mice carrying a major histocompatibility complex-I-
restricted Tg TCR for OVA257264 (SIINFEKL), originally provided
by F Carbone (Melbourne, Australia) (Hogquist et al., 1994), were
crossed with (Ly5.1þ ) Ptprca mice to generate mice bearing
Ly5.1þOT-I cells. RAG/2C mice (a cross between RAG/ and 2C
Tg mice) were provided by B Fazekas (Sydney, Australia) (Sha et al.,
1988). TCRd/ mice were obtained from Jackson Laboratory
(Bar Harbor, ME). TCRd/ were crossed with K5mOVA mice, and
the F1 generation was backcrossed with TCRd/ in order to generate
TCRd/OVAþ / mice. The same breeding strategy was used to
generate Ly5.1þ TCRd/ congenic mice by crossing Ly5.1þ Ptprca
mice with TCRd/ mice. All mice were bred under specific pathogen-
free conditions at the Princess Alexandra Hospital Biological
Research Facility. Age- and sex-matched animals of 6–10 weeks of
age were used in experiments. All animal procedures were approved
by the University of Queensland Animal Ethics Committee.
Reagents and flow cytometry
OVA257264 peptide, a H-2K
b-restricted cytotoxic T lymphocyte
epitope with the amino-acid sequence SIINFEKL, was purchased
from Auspep (Melbourne, Australia) with 480% purity, dissolved in
100% DMSO, and stored at 20 1C.
Anti-mouse mAbs to CD3 (145-2C11), CD8 (53-6.7), CD45.1
(A20), TCR-Va2 (B20.1), major histocompatibility complex-II (M5/
114.15.2), CD11c (N418), and CD40 (HM40-3), and associated
isotype control Igs, were purchased from BD Biosciences (San Jose,
CA), eBioscience (San Diego, CA). Before antibody staining, Fc
block (Fcg III/II receptor; BD Biosciences) was added to the cell
suspension for 10min on ice. Stained samples were analyzed on
FACSCalibur flow cytometer (BD Biosceinces).
Skin transplantation
Skin from donor mice was transplanted onto the flank of recipient
mice as previously described (Dunn et al., 1997; Matsumoto et al.,
2004). Briefly, donor skin was taken from the dorsal and ventral
surfaces of the ear (B1 cm2) and placed onto the thoracic flank
region of anaesthetized recipients. Grafts were held in place with
antibiotic-permeated gauze (Bactigras; Smith and Nephew, London,
UK) and bandaged with micropore tape and Flex-wrap (Lyppard,
Queensland, Australia). Bandages were removed 7 days after
grafting, and grafts were monitored daily for loss of distinct border
and signs of ulceration or necrosis to 480% of the graft, which was
used to define graft rejection.
Preparation of single-cell suspension from skin for flow
cytometry
Naive or grafted ear skin was digested by floating dermis side down
in 1mgml–1 collagenase/dispase solution (Roche, Berlin, Germany)
for 1 h at 37 1C. At the end of incubation, epidermal sheets were
separated from the dermis using forceps and transferred into
complete RPMI 1640 medium containing 10% fetal calf serum and
disrupted by vigorous pipetting with a transfer pipette. Cells were
then washed through a 70-mm cell strainer (BD Biosciences).
In vivo assays and immunizations
To assess the proliferation of OVA-specific CD8þ T cells in vivo,
Ly5.1þ . OT-I splenocytes were labeled with 2.5 mM CFSE and
injected intravenously (5 106) into the tail vein of OVA-immu-
nized, OVA Tg, or OVA-grafted wild-type and gd T-cell–deficient
mice. At 7 days and 42 h after transfer into OVA-immunized, OVA
Tg, or OVA-grafted mice, spleens and lymph nodes were harvested,
and CFSE dilutions in CD45.1þ Va2þ CD8þ were assessed by
FACS. When taking skin DLNs, brachial, axillary, and inguinal
lymph nodes were harvested based on their proximity to skin grafts
and increased size compared with uninvolved, contralateral lymph
nodes. Proliferation indices were calculated using the ModFit LT
software (Verity Software House, Topsham, ME). A total of 1 103
in vitro-activated OT-I cells, provided by T Kenna (Kenna et al.,
2010), were injected intravenously via the tail vein into RAG2/C
mice. To evaluate immune responses to soluble Ags, mice were
immunized subcutaneously in the tail base with 50 mg OVA (Grade
5; Sigma-Aldrich, St Louis, MO) and 20 mg QuilA adjuvant (Soperfos
Biosector DK-Vedback, Denmark). Negative control mice were
immunized with 20 mg QuilA only.
IFN-c ELISPOT
ELISPOT assays were performed as previously described (Narayan
et al., 2007). Briefly, cells from spleens of OVA-immunized or OVA-
grafted mice were cultured overnight in complete RPMI 1640
medium in the presence of 5 ngml–1 recombinant mouse IL-2 (BD
Biosciences) and 0.1 mM SIINFEKL peptide in ELISPOT assays. IFN-g
spot-forming units were counted using an ELISPOT plate reader and
stipulated as spot-forming units per 5 105 splenocytes.
In vivo CD8 T-cell depletion
CD8 T cells were depleted by intraperitoneal administration of anti-
CD8b-depleting antibody (clone 53-5.8) at days 2, 0, and þ 7
relative to skin transplantation using 100, 100, and 150 mg mAb per
mouse at each time point, respectively. An equal amount of purified
rat serum (isotype control) was injected into control mice. Two days
after the last injection (day þ 9), mice were eye-bled and tested for
efficacy of depletion, which was consistently 498%.
FITC painting
Flank skin was shaved with clippers and painted with 50 ml of
5mgml–1 FITC solution in a 1:1 ratio of acetone:dibutylphthalate
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(Sigma-Aldrich). DLNs were harvested 4 days after painting and
analyzed by FACS for major histocompatibility complex-IIhi CD11chi
FITCþ cells (migrating DCs). In the case of painting grafted mice,
bandages were removed from mice 4 days after grafting, and mice
were painted on the graft at day 5 after grafting with 10 ml of
25mgml–1 FITC solution.
Statistics
Kaplan–Meier plots were used to analyze skin graft survival, and a
log-rank test was performed to assess the statistical significance of
differences between survival curves. For all other data in which
statistics were performed, a two-tailed, nonparametric Mann–
Whitney test was used for assessment of differences between groups.
Differences with a P-valueo0.05 were considered to be significant.
Prism (Graphpad Software, La Jolla, CA) was used for graphs and
statistical analysis.
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